J. Harland

2.1k total citations
24 papers, 1.7k citations indexed

About

J. Harland is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, J. Harland has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 13 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in J. Harland's work include Herpesvirus Infections and Treatments (21 papers), Virus-based gene therapy research (13 papers) and Cytomegalovirus and herpesvirus research (8 papers). J. Harland is often cited by papers focused on Herpesvirus Infections and Treatments (21 papers), Virus-based gene therapy research (13 papers) and Cytomegalovirus and herpesvirus research (8 papers). J. Harland collaborates with scholars based in United Kingdom and Slovakia. J. Harland's co-authors include Stuart M. Brown, Alasdair Maclean, Vakis Papanastassiou, R Rampling, Donald M. Hadley, Richard Petty, James A. R. Nicoll, M. Brown, E. A. McKie and Matthew Fraser and has published in prestigious journals such as Journal of Virology, Brain Research and European Journal of Neuroscience.

In The Last Decade

J. Harland

24 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Harland United Kingdom	16	1.3k	940	710	632	237	24	1.7k
Kevin A. Cassady United States	23	887 0.7×	661 0.7×	557 0.8×	695 1.1×	408 1.7×	59	1.6k
R. S. Coffin United Kingdom	21	820 0.6×	377 0.4×	761 1.1×	534 0.8×	263 1.1×	43	1.7k
Jacqueline N. Parker United States	17	1.1k 0.9×	506 0.5×	643 0.9×	854 1.4×	269 1.1×	24	1.5k
C. Halbert United States	12	556 0.4×	623 0.7×	736 1.0×	570 0.9×	201 0.8×	25	1.6k
Carlos E. Ibañez United States	20	516 0.4×	389 0.4×	644 0.9×	333 0.5×	379 1.6×	37	1.4k
Caroline E. Lilley United States	20	674 0.5×	909 1.0×	1.1k 1.6×	471 0.7×	450 1.9×	23	2.2k
D. Valerio Netherlands	23	1.1k 0.8×	402 0.4×	1.3k 1.8×	384 0.6×	215 0.9×	40	1.9k
Samita Andreansky United States	20	630 0.5×	786 0.8×	515 0.7×	449 0.7×	855 3.6×	34	1.8k
Anna Salvetti France	31	1.5k 1.2×	635 0.7×	1.6k 2.3×	422 0.7×	222 0.9×	81	2.5k
Laura Menotti Italy	27	906 0.7×	1.7k 1.8×	589 0.8×	530 0.8×	570 2.4×	43	2.4k

Countries citing papers authored by J. Harland

Since Specialization

Citations

This map shows the geographic impact of J. Harland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Harland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Harland more than expected).

Fields of papers citing papers by J. Harland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Harland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Harland. The network helps show where J. Harland may publish in the future.

Co-authorship network of co-authors of J. Harland

This figure shows the co-authorship network connecting the top 25 collaborators of J. Harland. A scholar is included among the top collaborators of J. Harland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Harland. J. Harland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Imai, Hideaki, Lindsay Gallagher, David I. Graham, et al.. (2005). Evolution of GADD34 expression after focal cerebral ischaemia. Brain Research. 1034(1-2). 51–61. 10 indexed citations

2.

Mairs, R., Julia Brown, J. Harland, et al.. (2005). Assessment In Vitro of a Novel Therapeutic Strategy for Glioma, Combining Herpes Simplex Virus HSV1716-mediated Oncolysis with Gene Transfer and Targeted Radiotherapy. Medicinal Chemistry. 1(5). 423–429. 12 indexed citations

3.

Harrow, Stephen, Vakis Papanastassiou, J. Harland, et al.. (2004). HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival. Gene Therapy. 11(22). 1648–1658. 258 indexed citations

4.

White, F. E., et al.. (2004). Up‐regulation of a growth arrest and DNA damage protein (GADD34) in the ischaemic human brain: implications for protein synthesis regulation and DNA repair. Neuropathology and Applied Neurobiology. 30(6). 683–691. 9 indexed citations

5.

Detta, A., et al.. (2003). Proliferative activity and in vitro replication of HSV1716 in human metastatic brain tumours. The Journal of Gene Medicine. 5(8). 681–689. 20 indexed citations

6.

Harland, J., et al.. (2003). The Herpes Simplex Virus (HSV) Protein ICP34.5 is a Virion Component that Forms a DNA-Binding Complex with Proliferating Cell Nuclear Antigen and HSV Replication Proteins. Journal of NeuroVirology. 9(4). 477–488. 41 indexed citations

7.

Harland, J., et al.. (2003). The Herpes Simplex Virus (HSV) Protein ICP34.5 is a Virion Component that Forms a DNA-Binding Complex with Proliferating Cell Nuclear Antigen and HSV Replication Proteins. Journal of NeuroVirology. 9(4). 477–488. 2 indexed citations

8.

Imai, Hirotaka, J. Harland, James McCulloch, et al.. (2002). Specific expression of the cell cycle regulation proteins, GADD34 and PCNA, in the peri‐infarct zone after focal cerebral ischaemia in the rat. European Journal of Neuroscience. 15(12). 1929–1936. 34 indexed citations

9.

Harland, J., Vakis Papanastassiou, & Stuart M. Brown. (2002). HSV1716 persistence in primary human glioma cells in vitro. Gene Therapy. 9(17). 1194–1198. 20 indexed citations

10.

Papanastassiou, Vakis, R Rampling, Matthew Fraser, et al.. (2002). The potential for efficacy of the modified (ICP 34.5−) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study. Gene Therapy. 9(6). 398–406. 255 indexed citations

11.

Rampling, R, G. Cruickshank, Vakis Papanastassiou, et al.. (2000). Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Therapy. 7(10). 859–866. 478 indexed citations

12.

Harland, J., Salwa Bdour, Stuart M. Brown, & Alasdair Maclean. (1996). The herpes simplex virus type 2 strain HG52 RL1 gene contains a 154 bp intron as predicted from sequence analysis. Journal of General Virology. 77(3). 481–484. 3 indexed citations

13.

Brown, S. M., Alasdair Maclean, J D Aitken, & J. Harland. (1994). ICP34.5 influences herpes simplex virus type 1 maturation and egress from infected cells in vitro. Journal of General Virology. 75(12). 3679–3686. 73 indexed citations

14.

Brown, Stuart M., J. Harland, Alasdair Maclean, Jürgen Podlech, & J. Barklie Clements. (1994). Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. Journal of General Virology. 75(9). 2367–2377. 81 indexed citations

15.

Brown, S. M., J. H. Subak‐Sharpe, J. Harland, & Alasdair Maclean. (1992). Analysis of intrastrain recombination in herpes simplex virus type 1 strain 17 and herpes simplex virus type 2 strain HG52 using restriction endonuclease sites as unselected markers and temperature-sensitive lesions as selected markers. Journal of General Virology. 73(2). 293–301. 27 indexed citations

16.

Harland, J., et al.. (1992). A HSV-1 variant (1720) generates four equimolar isomers despite a 9200-bp deletion from TRL and sequences between 9200 np and 97,000 np in inverted orientation being covalently bound to sequences 94,000–126,372 np. Virus Genes. 6(3). 291–299. 3 indexed citations

17.

Maclean, Alasdair, et al.. (1991). Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence. Journal of General Virology. 72(3). 631–639. 219 indexed citations

18.

Harland, J. & S. M. Brown. (1989). A Herpes Simplex Virus Type 2 Variant in which a Deletion across the L-S Junction Is Replaced by Single or Multiple Reiterations of Extraneous DNA. Journal of General Virology. 70(8). 2121–2137. 8 indexed citations

19.

Harland, J. & Stuart M. Brown. (1988). Generation of a Herpes Simplex Virus Type 2 Variant Devoid of XbaI Sites: Removal of the 0.91 Map Coordinate Site Results in Impaired Synthesis of Glycoprotein G-2. Journal of General Virology. 69(1). 113–124. 14 indexed citations

20.

Harland, J. & S. M. Brown. (1985). Isolation and Characterization of Deletion Mutants of Herpes Simplex Virus Type 2 (Strain HG52). Journal of General Virology. 66(6). 1305–1321. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact